|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Costs of services (excludes depreciation and amortization and restructuring costs) | |||||
| Selling, general and administrative (excludes depreciation and amortization and restructuring costs) | |||||
| Depreciation and amortization | |||||
| Goodwill impairment losses | |||||
| Restructuring costs | |||||
| Interest expense | |||||
| Interest income | |||||
| Debt extinguishment costs | |||||
| Gain on disposition of businesses | |||||
| Gain on arbitration award | |||||
| Other expense (income), net | |||||
| Total costs and expenses | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Less: net income (loss) attributable to non-controlling interest, net of tax | |||||
| Net income attributable to DXC common stockholders | |||||
| Income per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) |
Loading...